Teriflunomide safety in subsets of patients with relapsing MS: Results from the TEMSO and TOWER studies

Authors
Category Primary study
ConferenceMultiple Sclerosis
Year 2015
This article has no abstract
Epistemonikos ID: c55a2c4fd984bac9d8fe82244eee62f2ca1b017a
First added on: Apr 30, 2026